Fertility Assessment and Treatment Plan
Both partners must be evaluated simultaneously from the outset, with the male partner undergoing comprehensive assessment including medical/reproductive history, physical examination, semen analysis (repeated if abnormal), and hormonal evaluation, while the female partner receives concurrent evaluation of ovulatory function, uterine anatomy, and tubal patency. 1
Initial Evaluation Timeline
Begin fertility evaluation after 12 months of regular unprotected intercourse for couples where the female partner is under 35 years old 1. However, initiate evaluation earlier if:
- Female partner is ≥35 years old
- Known risk factors for infertility exist in either partner
- History of failed ART cycles or recurrent pregnancy losses (≥2) 2
Male Partner Assessment
Essential Components (All Men)
Medical and Reproductive History should specifically address 1:
- Previous fertility outcomes
- Sexual function and ejaculatory disorders
- Medication usage (particularly testosterone, anabolic steroids, chemotherapy)
- Environmental and occupational exposures
- Lifestyle factors (smoking, alcohol, obesity)
- History of cryptorchidism, varicocele, infections, trauma
Physical Examination must evaluate 1:
- Testicular size and consistency (normal vs. atrophic)
- Epididymal fullness or induration
- Presence/absence of vas deferens bilaterally
- Varicocele detection
Semen Analysis (WHO reference values) 1, 2:
- If normal: single test sufficient
- If abnormal: repeat at least once, ideally 1 month apart, before proceeding with further workup
- Must be performed in specialized andrology laboratory (point-of-care/mail-in tests insufficient for comprehensive evaluation) 2
Hormonal Evaluation should include 1:
- FSH levels (helps distinguish obstructive vs. non-obstructive azoospermia)
- Additional hormones based on clinical findings
Additional Male Testing (Based on Initial Findings)
For Azoospermia 2:
- Centrifuge ejaculate and examine pellet for rare sperm
- FSH level interpretation:
- FSH <7.6 IU/L + normal testicular size + dilated epididymides = likely obstructive azoospermia
- FSH >7.6 IU/L + atrophic testes = likely non-obstructive azoospermia (spermatogenic failure)
- Consider genetic testing (karyotype, Y-chromosome microdeletion)
For Failed ART or Recurrent Pregnancy Loss 2:
- Karyotype analysis
- Sperm DNA fragmentation testing
- Referral to male reproductive specialist
Consider Oxidative Stress Assessment 1:
- Particularly relevant with poor lifestyle factors (smoking) or environmental exposures
- May guide antioxidant therapy and lifestyle interventions
Female Partner Assessment
Core Evaluation
- Serum progesterone level at cycle day 21 to document ovulation
- Assessment for ovulatory dysfunction
Uterine and Tubal Assessment 1, 3, 4:
- Hysterosalpingography (HSG) for women with no risk factors for tubal obstruction
- Hysteroscopy or laparoscopy for women with:
- History of endometriosis
- Previous pelvic infections
- Prior ectopic pregnancy
- Suspected uterine abnormalities or leiomyomas
Additional Imaging 1:
- Ultrasonography for initial uterine/ovarian assessment
- Pelvic MRI when indicated for detailed evaluation
Ovarian Reserve Assessment 3:
- Particularly important for women ≥35 years
Diagnostic Categorization
This comprehensive approach reduces "idiopathic infertility" to approximately 8% of couples 5. Common identifiable male factors include:
- Genital tract inflammation (48.8% of male factor cases) 5
- Genital tract infection (43.1%) 5
- Hypospermatogenesis (16.7%) 5
- Varicocele
- Obstructive vs. non-obstructive azoospermia
Treatment Algorithm Based on Findings
Male Factor Treatment
Infections/Inflammation 5:
- Antibiotics + probiotics for documented infections
- If inflammation persists: low-dose corticosteroids + antioxidants
Hypospermatogenesis 5:
- FSH treatment
Varicocele 5:
- Surgical repair when indicated
Abnormal Sperm Parameters 2, 4:
- Gonadotropin therapy
- Intrauterine insemination (IUI)
- In vitro fertilization (IVF) with or without ICSI
Female Factor Treatment
Anovulation 4:
- Clomiphene citrate for ovulation induction (can be initiated in primary care)
Tubal Obstruction 4:
- Requires subspecialty referral for surgical management
Unexplained Infertility
Options include 4:
- Another year of unprotected intercourse
- Intrauterine insemination
- In vitro fertilization
Critical Pitfalls to Avoid
Do not skip male evaluation: 50% of infertility involves male factors, and some conditions are life-threatening or have genetic implications 1, 2
Do not rely on single abnormal semen analysis: Semen parameters are highly variable; repeat testing is essential 2
Do not use semen analysis alone to determine fertility: It provides important information but cannot definitively distinguish fertile from infertile men 1
Do not proceed directly to ART without comprehensive evaluation: Targeted treatment based on identified causes achieves natural pregnancy in 40.9% of couples 5
Do not accept "idiopathic" diagnosis prematurely: Thorough evaluation identifies causative factors in >90% of cases 5
Lifestyle Modifications (All Couples)
- Limit alcohol intake
- Avoid tobacco and illicit drugs
- Achieve healthy weight (if obese)
- Reduce environmental/occupational exposures
- Consider antioxidant supplementation for oxidative stress